NEWS
Spotting threats hidden by encryption

By Patrice Puichaud, Senior Director EMEA, SentinelOne.

Read More
It’s time to think differently about segmentation

By Paul Darby, Regional Director, EMEA, Vidder.

Read More
Insider Threat: Focusing from The Inside Out

By Se?n McGurk, Executive Director of Advisory Services at Flashpoint and Jonathan Couch, SVP of...

Read More
Passport to protection

Aryaka, global SD-WAN provider, has unveiled PASSPORT, its multi-layered security platform and...

Read More
What to do when hit by ransomware

When faced with an attack, it’s not uncommon for business owners to panic.  However, whilst...

Read More
Moving endpoint security to the Cloud offers peace of mind

By Brian Gladstein, Cybersecurity Market Strategist, Carbon Black.

Read More

Videos

Alex Sharp, Chief Projects Officer, Data Centres at Nscale, outlines the scale of the AI data centre challenge – with average rack consuming 130 kilowatts of power, and as chips become more sophisticated, so...
Tim Whiteley, Cofounder of Inevidesk, has added three new partners to its channel partner programme, as part of its commitment to bringing the benefits of virtual desktop infrastructure (VDI) to the widest...
Kenneth Tan, Executive Director at Sardina Systems, Philip Kaye, Co-Founder and Director at Vespertec and Kristófer Andri Kristinsson, Product Manager and Business Development Manager at Borealis Data Center,...
Neil Fowler, SVP of Hybrid Cloud Engineering at Rocket Software, discusses the challenges and opportunities of IT modernisation, offering some valuable insights as to the essential ingredients of a successful...

News

Ransom attacks in the cloud are a perennially popular topic of discussion in the cloud security realm.
NTT DATA research shows organizations shifting from experiments to investments that drive performance.
Channel partners can now use customised AI assistants, powered by ArrowSphere AI, to reinvent the way they manage business operations and engage with their customers.
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.